b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="jbb" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2723995/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Generation and Characterization of Novel Human IRAS Monoclonal Antibodies</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723995/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Biomedicine and Biotechnology" /><meta name="citation_title" content="Generation and Characterization of Novel Human IRAS Monoclonal Antibodies" /><meta name="citation_authors" content="Bo Wang, Ying Liu, Yajun Shan, Zhenyu Yao, Xiaolan Liu, Ruibin Su, Qihong Sun, Yuwen Cong, Jin Li" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="2009" /><meta name="citation_doi" content="10.1155/2009/973754" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2723995/?report=abstract" /><meta name="citation_pmid" content="19672324" /><meta name="DC.Title" content="Generation and Characterization of Novel Human IRAS Monoclonal Antibodies" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Hindawi Limited" /><meta name="DC.Contributor" content="Bo Wang" /><meta name="DC.Contributor" content="Ying Liu" /><meta name="DC.Contributor" content="Yajun Shan" /><meta name="DC.Contributor" content="Zhenyu Yao" /><meta name="DC.Contributor" content="Xiaolan Liu" /><meta name="DC.Contributor" content="Ruibin Su" /><meta name="DC.Contributor" content="Qihong Sun" /><meta name="DC.Contributor" content="Yuwen Cong" /><meta name="DC.Contributor" content="Jin Li" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1155/2009/973754" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Generation and Characterization of Novel Human IRAS Monoclonal Antibodies" /><meta property="og:type" content="article" /><meta property="og:description" content="Imidazoline receptors were first proposed by Bousquet et al., when they studied antihypertensive effect of clonidine. A strong candidate for I1R, known as imidazoline receptor antisera-selected protein (IRAS), has been cloned from human hippocampus. We ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723995/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jbb.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2723995/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2723995/pdf/JBB2009-973754.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A87D7E9A471110000000000980098.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/94/">J Biomed Biotechnol</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/173107/">v.2009; 2009</a></li><li class="accid">PMC2723995</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jbb.gif" alt="Logo of jbb" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,57" alt="Journal\'s Home" title="Journal\'s Home" href="http://www.hindawi.com/journals/jbb/" ref="reftype=publisher&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="370,58,500,75" alt="Manuscript Submission" title="Manuscript Submission" href="http://mts.hindawi.com" ref="reftype=publisher&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="264,58,369,75" alt="Aims and Scope" title="Aims and Scope" href="http://www.hindawi.com/journals/jbb/aims.html" ref="reftype=publisher&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="148,58,263,75" alt="Author Guidelines" title="Author Guidelines" href="http://www.hindawi.com/journals/jbb/guidelines.html" ref="reftype=publisher&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="49,58,147,75" alt="Editorial Board" title="Editorial Board" href="http://www.hindawi.com/journals/jbb/editors.html" ref="reftype=publisher&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,58,48,75" alt="Home" title="Home" href="http://www.hindawi.com/journals/jbb/" ref="reftype=publisher&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">J Biomed Biotechnol</span>. 2009; 2009: 973754. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Aug 10. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1155%2F2009%2F973754" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1155/2009/973754</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2723995</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19672324">19672324</a></div></div></div></div><h1 class="content-title">Generation and Characterization of Novel Human IRAS Monoclonal Antibodies</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Wang%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567213076416" co-class="co-affbox">Bo Wang</a>,<sup>1</sup> <a href="/pubmed/?term=Liu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567170521376" co-class="co-affbox">Ying Liu</a>,<sup>1</sup> <a href="/pubmed/?term=Shan%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567213072656" co-class="co-affbox">Yajun Shan</a>,<sup>2</sup> <a href="/pubmed/?term=Yao%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567207127792" co-class="co-affbox">Zhenyu Yao</a>,<sup>2</sup> <a href="/pubmed/?term=Liu%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567207125664" co-class="co-affbox">Xiaolan Liu</a>,<sup>2</sup> <a href="/pubmed/?term=Su%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567170208672" co-class="co-affbox">Ruibin Su</a>,<sup>1</sup> <a href="/pubmed/?term=Sun%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567170206320" co-class="co-affbox">Qihong Sun</a>,<sup>2</sup> <a href="/pubmed/?term=Cong%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567170203968" co-class="co-affbox">Yuwen Cong</a>,<sup>2</sup> and  <a href="/pubmed/?term=Li%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324" class="affpopup" co-rid="_co_idm140567170201616" co-class="co-affbox">Jin Li</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140567213076416"><h3 class="no_margin">Bo Wang</h3><p><sup>1</sup>Department of Pharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Wang%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Bo Wang</a></div></div><div id="_co_idm140567170521376"><h3 class="no_margin">Ying Liu</h3><p><sup>1</sup>Department of Pharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Liu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Ying Liu</a></div></div><div id="_co_idm140567213072656"><h3 class="no_margin">Yajun Shan</h3><p><sup>2</sup>Department of Pathophysiology, Beijing Institute of Radiation Medicine, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Shan%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Yajun Shan</a></div></div><div id="_co_idm140567207127792"><h3 class="no_margin">Zhenyu Yao</h3><p><sup>2</sup>Department of Pathophysiology, Beijing Institute of Radiation Medicine, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Yao%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Zhenyu Yao</a></div></div><div id="_co_idm140567207125664"><h3 class="no_margin">Xiaolan Liu</h3><p><sup>2</sup>Department of Pathophysiology, Beijing Institute of Radiation Medicine, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Liu%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Xiaolan Liu</a></div></div><div id="_co_idm140567170208672"><h3 class="no_margin">Ruibin Su</h3><p><sup>1</sup>Department of Pharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Su%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Ruibin Su</a></div></div><div id="_co_idm140567170206320"><h3 class="no_margin">Qihong Sun</h3><p><sup>2</sup>Department of Pathophysiology, Beijing Institute of Radiation Medicine, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Sun%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Qihong Sun</a></div></div><div id="_co_idm140567170203968"><h3 class="no_margin">Yuwen Cong</h3><p><sup>2</sup>Department of Pathophysiology, Beijing Institute of Radiation Medicine, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Cong%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Yuwen Cong</a></div></div><div id="_co_idm140567170201616"><h3 class="no_margin">Jin Li</h3><p><sup>1</sup>Department of Pharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China</p><div>Find articles by <a href="/pubmed/?term=Li%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19672324">Jin Li</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140567207513328_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140567207513328_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140567207513328_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140567207513328_ai" style="display:none"><div class="fm-affl" lang="en" id="I1"><sup>1</sup>Department of Pharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China</div><div class="fm-affl" lang="en" id="I2"><sup>2</sup>Department of Pathophysiology, Beijing Institute of Radiation Medicine, Beijing 100850, China</div><div id="cor1">*Jin Li: <a href="mailto:dev@null" data-email="moc.oohay@2089ilnij" class="oemail">moc.oohay@2089ilnij</a></div><div id="idm140567170195680">Recommended by Val J. Watts</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140567207513328_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Feb 10; Revised 2009 May 18; Accepted 2009 Jun 5.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140567207513328_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2009 Bo Wang et al.</div><div class="license half_rhythm">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2723995/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140567137871040" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140567137871040title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">Imidazoline receptors were first proposed by Bousquet et al., when they studied antihypertensive effect of clonidine. A strong candidate for I1R, known as imidazoline receptor antisera-selected protein (IRAS), has been cloned from human hippocampus. We reported that IRAS mediated agmatine-induced inhibition of opioid dependence in morphine-dependent cells. To elucidate the functional and structure properties of I1R, we developed the newly monoclonal antibody against the N-terminal hIRAS region including the PX domain (10&#x02013;120aa) through immunization of BALB/c mice with the NusA-IRAS fusion protein containing an IRAS N-terminal (10&#x02013;120aa). Stable hybridoma cell lines were established and monoclonal antibodies specifically recognized full-length IRAS proteins in their native state by immunoblotting and immunoprecipitation. Monoclonal antibodies stained in a predominantly punctate cytoplasmic pattern when applied to IRAS-transfected HEK293 cells by indirect immunofluorescence assays and demonstrated excellent reactivity in flow immunocytometry. These monoclonal antibodies will provide powerful reagents for the further investigation of hIRAS protein functions.</p></div></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">1. Introduction</h2><p id="__p3" class="p p-first">Imidazoline receptors were first proposed by Bousquet et al., when they studied antihypertensive effect of clonidine [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793148">1</a>]. Based on their physiologic and pharmacological properties, imidazoline receptors are classified into three main types: I1R, I2R, and I3R [<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793139">2</a>&#x02013;<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793143">4</a>]. I1R and I2R have been implicated in hypertension and psychiatric disorder regulation, respectively, while I3R may be involved in insulin secretion [<a href="#B5" rid="B5" class=" bibr popnode">5</a>&#x02013;<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793147">9</a>]. Compared with mitochondrial I2R, which resides within the monoamine oxidase protein [<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793137">10</a>], the clonidine-preferring imidazoline binding sites (known as I1R) are localized to plasma membrane fractions [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793142">11</a>, <a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793154">12</a>] and specifically to synaptic plasma membranes [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793149">13</a>].</p><p id="__p4">A strong candidate for I1R, known as imidazoline receptor antisera-selected protein (IRAS), has been cloned from human hippocampus [<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793153">14</a>]. hIRAS is a larger protein of 1504 amino acids consisting of an NH<sub>2</sub>-terminal phox (PX) domain, 5 putative leucine-rich repeats, a predicted coiled-coil domain, and a long COOH-terminal region. Several evidence supported the identity of native I1R and IRAS protein in tissue distributions, ligand binding properties, some cellular functions and downstream signal pathways [<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793136">14</a>&#x02013;<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793141">18</a>]. The murine form of IRAS, Nischarin, truncated at the N-terminal 244 amino acids including the PX domain compared with the hIRAS, was a soluble cytosolic protein involved in cytoskeletal organization [<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793133">19</a>]. It has been shown that decreasing the expression of rat IRAS or Nischarin in PC12 rat pheochromocytoma cells could attenuate the activation of extracellular signal-regulated kinase (ERK) or reduce the radioligand binding to I1R, which further supported that hIRAS or Nischarin might serve as I1R itself, or at least a functional subunit of I1R [<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793146">20</a>]. Recently, Molderings et al. have reported that the &#x0201c;I1-imidazoline receptors&#x0201d; mediating effects of clonidine and moxonidine in PC12 and the transfected HEK293 cells belonged to the S1P-receptor family, in particular, representing a mixture of sphingosine-1-phosphate (S1P)1- and S1P3-receptors and/or heterodimers of both. It was then proposed that an increased expression of IRAS or Nischarin may improve the receptor-trafficking from cytosolic S1P-receptors to the cell membrane and thereby increase the number of binding sites in the plasma membrane for radioligand binding [<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793135">21</a>]. In our previous study, we also reported that IRAS mediated agmatine-induced inhibition of opioid dependence in morphine-dependent cells [<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793144">22</a>]. Despite intensive efforts, the molecular base of the I1R had not yet been elucidated.</p><p id="__p5" class="p p-last">To elucidate the functional and structure properties of I1R, several different epitope-specific antisera against IRAS have been raised in rabbits [<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793152">23</a>]. Because of IRAS splice variants or nonspecificity of these antisera, more sizes of IRAS (&#x02248;33, &#x02248;85, &#x02248;170 KDa) have been visualized in various tissue and cells, which limited their uses on western blot. IRAS was reported to target to the endosomes by a combined action of a PX domain and a coiled-coil region. The PX domain, consisting of 10&#x02013;130 amino acids, was first identified from the sequence analysis of two SH3 domain-containing cytosolic components of NADPH oxidase, p47<em>phox</em>  and p40<em>phox</em>  [<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793138">24</a>]. Therefore, in the present study, we developed the newly monoclonal antibody against the N-terminal hIRAS region including the PX domain (10&#x02013;120aa). This development has great utility for immunoblotting, indirect immunofluorescent staining, immunoprecipitation, and flow cytometry. These monoclonal antibodies will provide powerful reagents for the further investigation of hIRAS protein functions.</p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">2. Materials and Methods</h2><div id="sec2.1" class="sec sec-first"><h3 id="sec2.1title">2.1. Generation of the NusA-IRAS(10&#x02013;120aa) Fusion Protein</h3><p id="__p6" class="p p-first-last">E. coli BL21(DE3) (F-ompT gal dcm hsdSB (rB-mB-) <em>&#x003bb;</em> (DE3) (Novagen) cells were transformed with recombinant plasmid, pET43.1-IRAS(10&#x02013;120aa). Transformants were selected from ampicillin-containing Luria Bertani (LB) lates. Selected colonies were cultured in ampicillin-containing LB media. Isopropyl-<em>&#x003b2;</em>-D-thio galactopyranoside (IPTG) was added to a final concentration of 1 mM. The incubation was continued for 3 hours at 30&#x000b0;C. Cells were harvested, mixed with lysis buffer (phosphate buffered saline [pH 7.3], 1.0 mM EDTA, 1.0 mM phenylmethylsulfonyl fluoride, 0.5 mg/mL lysozyme (Roche)), and sonicated. The high-speed supernatant which contained the pET43.1-IRAS(10&#x02013;120aa) soluble protein fraction was loaded onto 10 mL Ni<sup>2+</sup>-NTA agarose columns. The fusion protein was eluted with lysis buffer with 400 mM imidazole. Eluted proteins were electrophoresed on SDS-PAGE gels. Expression yields were analyzed with the Quantity One quantitative software (Bio-Rad) based on relative band intensities of comassie blue stains. Purified proteins were detected with western blot using anti-His mAbs (Santa Cruz).</p></div><div id="sec2.2" class="sec"><h3 id="sec2.2title">2.2. Antiserum Titer Determination by Indirect Enzymelinked Immunosorbent Analysis (ELISA)</h3><p id="__p7" class="p p-first-last">The purified NusA-IRAS<sub>(10&#x02013;120aa)</sub>, diluted to 10 <em>&#x003bc;</em>g/mL in 50 mM carbonate salt buffer (pH 9.6), was coated on plates at 100 <em>&#x003bc;</em>L aliquot per well, 4&#x000b0;C overnight. The wells were washed three times with PBS-Tween buffer (0.05% Tween 20 in PBS). The coated wells were blocked with 200 <em>&#x003bc;</em>L of 3% BSA for 1 hour at 37&#x000b0;C and then incubated with 150 <em>&#x003bc;</em>L monoclonal antibodies against NusA-IRAS<sub>(10&#x02013;120aa)</sub> fusion protein with different dilutions (from 1 : 1000 to 1 : 25600). After incubation for 1 hour at 37&#x000b0;C, the wells were incubated with 150 <em>&#x003bc;</em>L horseradish peroxidase-conjugated goat antimouse IgG (dilution 1 : 5000, Santa Cruz) for 1 hour at 37&#x000b0;C after thorough washing. Peroxidase activity was detected using o-phenylenediamine and H<sub>2</sub>O<sub>2</sub>  as enzyme substrates. Color development was stopped with 2 M of H<sub>2</sub>SO<sub>4</sub>  and the absorbance was measured at 490 nm using Microplate Reader (Bio-Rad).</p></div><div id="sec2.3" class="sec"><h3 id="sec2.3title">2.3. Production of Antihuman IRAS Monoclonal Antibodies</h3><p id="__p8" class="p p-first-last">The purified NusA-IRAS<sub>(10&#x02013;120aa)</sub> protein (50 <em>&#x003bc;</em>g in a volume of 80 <em>&#x003bc;</em>L) was mixed with an equal volume of Freund\'s complete adjuvant. The antigen-adjuvant mixture was injected into 6 female BALB/c mice and was followed by three booster injections at 2-week interval in incomplete Freund\'s adjuvant. The mouse with the highest antibody titer tested by ELISA was boosted intraperitoneally with 100 <em>&#x003bc;</em>g NusA-IRAS<sub>(10&#x02013;120aa)</sub> protein without adjuvant 3 days before the cell fusion. Feeder layer cells were prepared 1 day prior to fusion. Splenocytes from mice with the highest ELISA antibody titers were fused with murine myeloma cells SP2/0 following standard procedures [<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793155">25</a>]. Culture supernatants were collected after fusion and initially screened by ELISA with purified NusA-IRAS<sub>(10&#x02013;120aa)</sub> fusion proteins as antigens. Positive hybridoma clones were selected with the limiting dilution method, and stable hybridoma clones were obtained after 3 cloning cycles. Isotypes of antibodies were identified with a mouse subisotype panel (Bio-Rad). The pristine-primed BALB/c mice were injected intraperitoneally with 1 &#x000d7; 10<sup>6</sup>  hybridoma cells per mouse in order to acquire abundant mAbs. The ascitic fluid was collected and mAbs were purified with a protein A/G affinity column (Amersham Pharmacia Biotech).</p></div><div id="sec2.4" class="sec"><h3 id="sec2.4title">2.4. Western Blotting Analysis</h3><p id="__p9" class="p p-first-last">Transfected cells were harvested 48 hours after transfection. Total cell lysate preparation and western blot analysis were performed according to previously described procedures [<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793140">26</a>]. In brief, cell lysates were prepared, electrophoresed on SDS-PAGE gels, and transferred to polyvinylidene difluoride (PVDF) membranes. Membranes were blocked with 5% nonfat milk in TBST (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 0.05% [v/v] Tween 20) and incubated with IRAS or GFP mAbs (Cell Signaling Technology Inc). Blots were incubated with horseradish peroxidase (HRP) conjugated goat antimouse antibodies (Santa Cruz) after primary antibody incubation, and blots were developed with enhanced electrochemiluminescence (ECL, Cell Signaling Technology Inc).</p></div><div id="sec2.5" class="sec"><h3 id="sec2.5title">2.5. Confocal Microscopy Analysis</h3><p id="__p10" class="p p-first-last">The cellular localization of the IRAS protein was identified according to previously described procedures [<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848030875">27</a>]. Cells on glass cover slips were rinsed with PBS, fixed with 3% paraformaldehyde for 30 minutes, and permeabilized with 0.2% [v/v] Triton X-100/PBS. Permeabilized cells were incubated with IRAS mAbs and TRITC-conjugated affinipure goat antimouse IgG (Santa Cruz) for 1 hour for immunofluorescence assays. Nuclei were stained with 0.1 mg/mL Hoechst33342 (Molecular Probes). Specimens were examined by confocal fluorescent microscopy on a Bio-Rad Radiance 2100 System.</p></div><div id="sec2.6" class="sec"><h3 id="sec2.6title">2.6. Immunoprecipitation Analysis</h3><p id="__p11" class="p p-first-last">The HEK293 cells were transfected with PCMV-myc-IRAS or PCMV-myc plasmid to analyze IRAS mAbs immunoprecipitated with IRAS. Cell lysates were prepared in a modified RIPA buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% [v/v] Nonidet P40, 0.5% [w/v] sodium deoxycholate) containing Complete Protease inhibitor Cocktail Tablets (Roche). Cell lysates were centrifuged to remove debris. Recovered lysates were incubated with IRAS or c-myc mAbs (Santa Cruz) overnight at 4&#x000b0;C followed by protein A/G agarose beads (50 <em>&#x003bc;</em>L, Santa Cruz) for another 3 hours to capture the immunoprecipitates. Recovered immune complexes were extensively washed in lysis buffer. Samples were boiled to release the bound proteins and appropriate supernatant aliquots were run on SDS-PAGE gels for western blot analysis as described above.</p></div><div id="sec2.7" class="sec"><h3 id="sec2.7title">2.7. Flow Cytometry</h3><p id="__p12" class="p p-first-last">Cells (2 &#x000d7; 10<sup>6</sup>) were transfected with PCMV-myc-IRAS for each sample and fixed with 70% [v/v] cold ethanol at 4&#x000b0;C overnight. Cells were permeabilized in 0.1% [v/v] Triton X-100/PBS and were incubated with IRAS or c-myc mAbs (Santa Cruz). Cells were washed and resuspended in an FITC-conjugated affinipure goat antimouse IgG (Santa Cruz). Finally, cells were washed twice and samples were analyzed on a flow immunocytometry machine (Becton-Dickinson) [<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793145">28</a>].</p></div><div id="sec2.8" class="sec"><h3 id="sec2.8title">2.8. Cell Culture and Transfection</h3><p id="__p13" class="p p-first-last">HEK293 cells were grown in Dulbecco\'s modified Eagle medium (DMEM) (Gibco BRL) supplemented with 10% fetal bovine serum. Cells were transfected with different plasmid DNAs using a Lipofectamine 2000 (Invitrogen) when cell densities reached 70% confluence per the manufacturer\'s instructions. Hybridoma cells were grown in DMEM with 10% fetal bovine serum.</p></div><div id="sec2.9" class="sec sec-last"><h3 id="sec2.9title">2.9. Construction of Expression Vector pET43.1a-IRAS, pCMV-myc-IRAS, and pEGFPC1-IRAS</h3><p id="__p14" class="p p-first-last">The cDNA fragment of the human IRAS N-terminal (10&#x02013;120aa) was inserted into the pET-43.1a(+) expression vector (Novagen) by PCR amplification of the human IRAS cDNA (<a id="__tag_721882619" class="tag_hotlink" href="/nuccore/AF082516" ref="/nuccore/AF082516"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AF082516","term_id":"3462806","term_text":"AF082516"}}</span>AF082516</a>) using the following oligomers: sense, 5&#x02032;-CGGGATCCATGGAGCGGGAAGCCGAGCCG-3&#x02032;, and antisense, 5&#x02032;-CGGAATTCATAGAAGTGAAAATGCAAGAAGTG-3&#x02032;. The full-length human IRAS was obtained by PCR amplification of the entire coding region, and the resulting 4512-bp PCR product was ligated into the pEGPC1 and PCMV-myc vectors in a similar fashion using the following oligomers, respectively: sense, 5&#x02032;-CGCGAATTCTATGGCGACCGCGCGCACCTTCG-3&#x02032;, and antisense, 5&#x02032;-CGGGATCCTAGCCGGTGAGCTCGACAGGC-3&#x02032;, sense, 5&#x02032;-CGCGAATTCGGATGGCGACCGCGCGCACCTTC-3&#x02032;, and antisense, 5&#x02032;-CCGCTCGAGCTAGCCGGTGAGCTCGACAGGC-3&#x02032;. All plasmid sequences were confirmed by sequencing analysis.</p></div></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">3. Results and Discussion</h2><div id="sec3.1" class="sec sec-first"><h3 id="sec3.1title">3.1. Generation of Murine Monoclonal Antibodies (mAbs) against a Recombinant NusA-IRA<strong>S</strong><sub>(10&#x02013;120<strong>a</strong><strong>a</strong>)</sub> Fusion Protein</h3><p id="__p15" class="p p-first">IRAS is a large protein comprising of 1504 amino acids. Its NH<sub>2</sub>-terminal phox domain is important for membrane association and cellular localization. The N-terminal of IRAS (10&#x02013;120aa) covering the PX domain was cloned into the pET-43.1a(+) (<a href="/pmc/articles/PMC2723995/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure 1(a)</span></a>) [<a href="#B29" rid="B29" class=" bibr popnode">29</a>]. The supernatant fusion protein was purified by His-tag affinity purification and was subsequently used to generate the monoclonal antibody. The dissolved protein yielded one major band of 78 kDa expected molecular weight (<a href="/pmc/articles/PMC2723995/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure 1(b)</span></a>) with high purity and integrity. The NusA protein used as a control generated the 66 kDa expected molecular weight. The recombinant protein was also confirmed with western blot using anti-His mAbs (right column, <a href="/pmc/articles/PMC2723995/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figure 1(b)</span></a>). BALB/c mice (<em>n</em> = 3) were immunized with the NusA-IRAS<sub>(10&#x02013;120aa)</sub> fusion protein, and blood was collected from the mice after multiple injections. Antibody titers were tested by ELISA on plates coated with the NusA-IRAS<sub>(10&#x02013;120aa)</sub> protein (data not shown). The 2 mice with the highest titers were sacrificed and spleens from both mice were fused to myeloma cells following standard procedures. Individual hybridomas was grown and 125 hybridomas were further characterized. Supernatant from the growing hybridoma clones was screened with ELISA. Screening was performed on plates coated with NusA-IRAS<sub>(10&#x02013;120aa)</sub>, NusA protein, and GST-IRAS<sub>(10&#x02013;120aa)</sub> fusion protein to determine antibody specificity. A total of 5 hybridomas (DA041, DD015, BE073, BA022, and AH021) reacted selectively with the NusA-IRAS<sub>(10&#x02013;120aa)</sub> protein in all 3 assays and were further evaluated. Isotype analysis revealed that all mAbs were of the IgG1 subtype.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC2723995/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140567138700496" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2723995_JBB2009-973754.001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is JBB2009-973754.001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2723995/bin/JBB2009-973754.001.jpg" /></a></div><div id="largeobj_idm140567138700496" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2723995/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC2723995/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p23">Production of immunogens for human IRAS. (a) Schematic representation of IRAS fusion used for mAb production. The IRAS N-terminal of the PX domain, and the Arg 10 to Glu 120 were expressed as the NusA fusion protein. LRR represents the leucine-rich repeats and CC represents the coiled-coiled region. Numbers represent amino acid positions. (b) Purification and western blot analysis of NusA-IRAS<sub>(10&#x02013;120aa)</sub> fusion proteins. SDS-PAGE analysis after filtration through the Ni<sup>2+</sup>-NTA column (left column) were then immunoblotted with the anti-His mAb (right column). Sizes (kDa) of molecular mass marker were indicated on the left side.</p></div></div></div><p id="__p16" class="p p-last">The immunoreactivities of the 5 representative mAbs with NusA-IRAS<sub>(10&#x02013;120aa)</sub> were shown in <a href="/pmc/articles/PMC2723995/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure 2</span></a>, all of which specifically recognized a 78 kDa protein band which corresponded to the purified NusA-IRAS<sub>(10&#x02013;120aa)</sub> protein, but not to the 66 kDa NusA protein. Anti-His mAbs reacted with both proteins in the same experiment (<a href="/pmc/articles/PMC2723995/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure 2(a)</span></a>) as controls. We evaluated the specificity of mAbs in mammalian cells by inserting IRAS cDNA into expression vectors to allow the production of GFP fusion proteins under the control of a CMV promoter. The pEGFPC1 and pEGFPC1-IRAS plasmids were separately transfected into HEK293 cells. Western blot analysis with the anti-GFP antibody demonstrated that chimeric proteins were expressed and migrated separately at expected molecular masses of approximately 19 or 27 KDa (<a href="/pmc/articles/PMC2723995/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure 2(b)</span></a>). However, the expected 190 kDa band whose molecular weight corresponded to the full-length IRAS protein was only detected with the mAbs DA041, DD015, and BE073 in GFP-IRAS expressed cells.  The remaining BA022 and AH021 mAbs were negative (<a href="/pmc/articles/PMC2723995/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Figure 2(b)</span></a>). The same samples were also incubated with preimmune serum with no reactivity (data not shown). Results revealed that all 5 selected mAbs specifically recognized bacterially expressed NusA-IRAS<sub>(10&#x02013;120aa)</sub> proteins, but only 3 mAbs recognized recombinant IRAS in mammalian cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC2723995/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140567138696640" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2723995_JBB2009-973754.002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is JBB2009-973754.002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2723995/bin/JBB2009-973754.002.jpg" /></a></div><div id="largeobj_idm140567138696640" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2723995/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC2723995/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p24">Verification of the specificity of the IRAS mAbs. (a) Identification by western blot using anti-His mAb or the mAbs DA041, DD015, BE073, BA022, and AH021 in NusA and NusA-IRAS<sub>(10&#x02013;120aa)</sub> recombinant proteins. (b) The whole cell extracts derived from HEK293 cells were transfected with pEGFPC1-IRAS and the control vector pEGFPC1 plasmid, respectively. Cell lysates were prepared 48 hours after transfection and were separated by SDS-PAGE. Proteins transferred to PVDF membranes were probed with anti-GFP antibody or the mAbs DA041, DD015, BE073, BA022, and AH021. Sizes (kDa) of molecular mass marker were indicated on the left side.</p></div></div></div></div><div id="sec3.2" class="sec"><h3 id="sec3.2title">3.2. Cellular Localization and Flow Cytometry Analysis for IRAS Expression</h3><p id="__p17" class="p p-first">IRAS mAbs were used to detect the cellular localization of IRAS protein based on specificity characterized by western blot analysis. The pEGFPC1-IRAS plasmid was transfected into HEK293 cells. IRAS protein localization was tested by fluorescence confocal microscopy after 48 hours transfection. GFP-IRAS was primarily located in the cytoplasm in a punctate pattern (<a href="/pmc/articles/PMC2723995/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure 3(a)</span></a>) with concentration onto discrete loci and spot fluorescence (panel A, E, I, M, and Q), as confirmed in previous studies [<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_176793134">30</a>]. The mAbs DA041, DD015, and BE073 were used as probes to detect a predominantly punctate cytosolic distribution as expected (panel B, F, G). However, the mAb BA022 homogenously detected the fluorescence distribution over the cytoplasm (panel N) and the mAb AH021 scored negatively (panel R). Merged images revealed that the GFP-IRAS fluorescence significantly coincided with the immunostaining with mAbs DA041, DD015, and BE073 (panel D, H, and L), but was not reflected by the mAbs BA022 and AH021 (panel P and T). Further, the punctate fluorescence patterns appeared to be unique to the mAbs DA041, DD015, and BE073. In addition, we also detected the endogenous IRAS protein with monoclonal antibody DA041 in PC12 cells, showing a strong signal associated with the membrane and faint signal in the cytoplasm (data not shown). These results suggest that the 3 mAbs specifically detect IRAS proteins by immunofluorescence, similar to immunoblotting results.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC2723995/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140567138691440" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2723995_JBB2009-973754.003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is JBB2009-973754.003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2723995/bin/JBB2009-973754.003.jpg" /></a></div><div id="largeobj_idm140567138691440" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2723995/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC2723995/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p25">Binding of IRAS mAbs to IRAS-expressing cells by immunofluorescence and flow cytometry analysis. (a) HEK293 cells were transfected with the plasmid pEGFPC1-IRAS. Cellular localization of IRAS was observed by scanning fluorescence confocal microscopy. Green represented EGFP fluorescence (A, E, I, M, and Q) from the GFP-IRAS fusion protein, blue (C, G, K, O, and S) fluorescence represented Hoechst stained cell nuclei, red (B, F, J, N, and R) fluorescence represented cells expressing GFP-IRAS labeled with TRITC-conjugated goat antimouse antibody using IRAS mAbs as the primary antibody, and yellow (D, H, L, P, and T) represented overlapping green and red fluorescence. All 3 panels had the same field of view. Scale bar, 100 <em>&#x003bc;</em>m. (b) Samples were collected and separately analyzed by flow cytometry for the ability to bind the preimmune serum (control), the c-myc mAb, and the mAb DA041 after 48 hours transfection of PCMV-myc-IRAS. Results were expressed as histograms with the DNA content on <em>x</em>-axis and the number of fluorescent cells on <em>y</em>-axis. Cells were distributed in 2 populations, and the second population (R2) with high fluorescence reflected the population of transfected cells recognized by the mAb DA041.</p></div></div></div><p id="__p18" class="p p-last">Flow cytometry is a rapid, quantitative, multiparameter cellular analysis based on the measurement of visible and fluorescent light emission. We chose the representative mAb DA041 for further characterization based on the strong signals detected by immunoblotting and immunofluorescence. The IRAS cDNA was cloned into the mammalian expression vector PCMV-myc and was expressed in HEK293 cells. The mAb DA041 and the c-myc mAb (used as a positive control) resulted in significant increases in fluorescence intensity when compared to cells incubated with preimmune serum (<a href="/pmc/articles/PMC2723995/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Figure 3(b)</span></a>). The binding efficiencies were 30.77% by the mAb DA041 and 48.26% by the c-myc mAb. No reactivities were detectable in preimmune sera (0.01%). These results indicate mAb DA041 is effective for detecting IRAS protein by flow cytometry.</p></div><div id="sec3.3" class="sec sec-last"><h3 id="sec3.3title">3.3. MAbs IRAS Immunoprecipitates IRAS from Cell Lysates</h3><p id="__p19" class="p p-first">We next characterized IRAS mAb ability to recognize IRAS proteins in their native states by immunoprecipitation. Cell extracts were immunoprecipitated with the mAb DA041 and analyzed with mAb DA041 immunoblotting after 48-hour transfection with PCMV-myc-IRAS. IRAS was selectively immunoprecipitated from cell lysates that expressed the myc-IRAS protein (approximately 175 kDa), and those which corresponded to the predicted size of the full-length IRAS (<a href="/pmc/articles/PMC2723995/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Figure 4</span></a>). Immunoprecipitation of lysates with mouse normal IgG did not result in detection of protein species. Lysates were immunoprecipitated with the c-myc mAb to confirm mAb specificity, and similarly sized bands were detected. No corresponding band was visualized when the negative control c-myc mAb was used to immunoprecipitate cell lysate of the transfectant expressing the empty PCMV-myc vector. Similar results were obtained with the mAbs DD015 and BE073 under the same conditions, and the remaining mAbs BA022 and AH021 scored negatively. Therefore, the 3 isolated antibodies specifically recognized native full-length IRAS protein products.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC2723995/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140567138688048" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2723995_JBB2009-973754.004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is JBB2009-973754.004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2723995/bin/JBB2009-973754.004.jpg" /></a></div><div id="largeobj_idm140567138688048" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2723995/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC2723995/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p26">Analysis of immunoprecipitates revealed that the IRAS mAbs specifically recognized the native state of the IRAS protein. The HEK293 cells were transiently transfected with the empty vector PCMV-myc (negative control) and PCMV-myc-IRAS. Whole cell lysates were prepared and immunoprecipitated with the c-myc mAb or the mAbs DA041, DD015, BE073, BA022, and AH021. Immunoprecipitation of the same lysates using mouse normal IgG did not result in the detection of any protein species. Immunocomplexes were analyzed by western blot with indicated antibodies.</p></div></div></div><p id="__p20">Our results suggested that the mAbs DA041, DD015, and BE073 were reactive for both immunofluorescence and immunoblotting. Therefore, these mAbs likely recognized linear epitopes in the IRAS protein. In addition, the 3 mAbs were capable of recognition of native full-length IRAS proteins by immunoprecipitation. However, the mAbs BA022 and AH021 specifically recognized bacterially expressed IRAS immunogens and did not detect recombinant IRAS in mammalian cells. This could be related to the different IRAS folding patterns, since misfolded IRAS proteins could result in the exposure of unique immunogenic epitopes different from native proteins. The mAbs BA022 and AH021 could be used as backup reagents to safeguard against antibody-specific artifacts. In addition, analyzing the overall homology of the amino acid sequence of the PX domain, Sorting Nexins 13 (SNX13) is the most relative protein to IRAS [<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_321240311">31</a>]. We found monoclonal antibody DA041 against hIRAS could not react with SNX13 by immunofluorescence assay (data not shown). It was proposed that these antibodies developed here were specific to the PX domain of IRAS.</p><p id="__p21" class="p p-last">In summary, we generated specific mAbs directed against the human IRAS N-terminal. The mAb DA041 exhibited the best performance in a variety of assays including immunoblotting, immunoprecipitation, indirect immunofluorescence stainning, and flow cytometry. Specific mAbs may provide an ideal reagent for further investigation of the function of IRAS proteins.</p></div></div><div id="idm140567208855824" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140567208855824title">Acknowledgments</h2><div class="sec"><p id="__p22">The authors would like to thank J. E. Piletz for kindly providing the IRAS-pcDNA3.1 plasmid and J. Q. Zheng for advice of English usages throughout the article and Zhiyi Zhang for the assay of confocal microscopy. This work was supported by the National Basic Research Program of China (no. 2003CB515400, no. 2007CB512307, and no. 2009CB202000), National Natural Science Foundation of China 30701016, Beijing Municipal Natural Science Foundation 7082073.</p></div></div><div id="idm140567208854480" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140567208854480title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. <span><span class="ref-journal"><em>Journal of Pharmacology and Experimental Therapeutics</em>. </span>1984;<span class="ref-vol">230</span>(1):232\xe2\x80\x93236.</span> [<a href="/pubmed/6146707" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;title=Central+cardiovascular+effects+of+alpha+adrenergic+drugs:+differences+between+catecholamines+and+imidazolines&amp;author=P+Bousquet&amp;author=J+Feldman&amp;author=J+Schwartz&amp;volume=230&amp;issue=1&amp;publication_year=1984&amp;pages=232-236&amp;pmid=6146707&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Ernsberger P, Graves ME, Graff LM, et al.  I1-imidazoline receptors: definition, characterization, distribution, and transmembrane signaling. <span><span class="ref-journal"><em>Annals of the New York Academy of Sciences</em>. </span>1995;<span class="ref-vol">763</span>:22\xe2\x80\x9342.</span> [<a href="/pubmed/7677333" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=I1-imidazoline+receptors:+definition,+characterization,+distribution,+and+transmembrane+signaling&amp;author=P+Ernsberger&amp;author=ME+Graves&amp;author=LM+Graff&amp;volume=763&amp;publication_year=1995&amp;pages=22-42&amp;pmid=7677333&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Tesson F, Parini A. Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex. <span><span class="ref-journal"><em>European Journal of Pharmacology</em>. </span>1991;<span class="ref-vol">208</span>(1):81\xe2\x80\x9383.</span> [<a href="/pubmed/1936130" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=European+Journal+of+Pharmacology&amp;title=Identification+of+an+imidazoline-guanidinium+receptive+site+in+mitochondria+from+rabbit+cerebral+cortex&amp;author=F+Tesson&amp;author=A+Parini&amp;volume=208&amp;issue=1&amp;publication_year=1991&amp;pages=81-83&amp;pmid=1936130&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Chan SLF, Brown CA, Scarpello KE, Morgan NG. The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and \n      I2-sites. <span><span class="ref-journal"><em>British Journal of Pharmacology</em>. </span>1994;<span class="ref-vol">112</span>(4):1065\xe2\x80\x931070.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1910228/">PMC free article</a>]</span> [<a href="/pubmed/7952865" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=British+Journal+of+Pharmacology&amp;title=The+imidazoline+site+involved+in+control+of+insulin+secretion:+characteristics+that+distinguish+it+from+I1-+and+&#10;++++++I2-sites&amp;author=SLF+Chan&amp;author=CA+Brown&amp;author=KE+Scarpello&amp;author=NG+Morgan&amp;volume=112&amp;issue=4&amp;publication_year=1994&amp;pages=1065-1070&amp;pmid=7952865&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Molderings GJ. Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnosis. <span><span class="ref-journal"><em>Drugs of the Future</em>. </span>1997;<span class="ref-vol">22</span>(7):757\xe2\x80\x93772.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs+of+the+Future&amp;title=Imidazoline+receptors:+basic+knowledge,+recent+advances+and+future+prospects+for+therapy+and+diagnosis&amp;author=GJ+Molderings&amp;volume=22&amp;issue=7&amp;publication_year=1997&amp;pages=757-772&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Ernsberger P, Damon TH, Graff LM, Sch&#x000e4;fer SG, Christen MO. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. <span><span class="ref-journal"><em>Journal of Pharmacology and Experimental Therapeutics</em>. </span>1993;<span class="ref-vol">264</span>(1):172\xe2\x80\x93182.</span> [<a href="/pubmed/8380858" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Pharmacology+and+Experimental+Therapeutics&amp;title=Moxonidine,+a+centrally+acting+antihypertensive+agent,+is+a+selective+ligand+for+I1-imidazoline+sites&amp;author=P+Ernsberger&amp;author=TH+Damon&amp;author=LM+Graff&amp;author=SG+Sch&#x000e4;fer&amp;author=MO+Christen&amp;volume=264&amp;issue=1&amp;publication_year=1993&amp;pages=172-182&amp;pmid=8380858&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Tesson F, Limon-Boulez I, Urban P, et al.  Localization of I2-imidazoline binding sites on monoamine oxidases. <span><span class="ref-journal"><em>Journal of Biological Chemistry</em>. </span>1995;<span class="ref-vol">270</span>(17):9856\xe2\x80\x939861.</span> [<a href="/pubmed/7730367" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Biological+Chemistry&amp;title=Localization+of+I2-imidazoline+binding+sites+on+monoamine+oxidases&amp;author=F+Tesson&amp;author=I+Limon-Boulez&amp;author=P+Urban&amp;volume=270&amp;issue=17&amp;publication_year=1995&amp;pages=9856-9861&amp;pmid=7730367&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Raddatz R, Parini A, Lanier SM. Localization of the imidazoline binding domain on monoamine oxidase B. <span><span class="ref-journal"><em>Molecular Pharmacology</em>. </span>1997;<span class="ref-vol">52</span>(4):549\xe2\x80\x93553.</span> [<a href="/pubmed/9380016" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Pharmacology&amp;title=Localization+of+the+imidazoline+binding+domain+on+monoamine+oxidase+B&amp;author=R+Raddatz&amp;author=A+Parini&amp;author=SM+Lanier&amp;volume=52&amp;issue=4&amp;publication_year=1997&amp;pages=549-553&amp;pmid=9380016&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Morgan NG, Chan SLF, Brown CA, Tsoli E. Characterization of the imidazoline binding site involved in regulation of insulin secretion. <span><span class="ref-journal"><em>Annals of the New York Academy of Sciences</em>. </span>1995;<span class="ref-vol">763</span>:361\xe2\x80\x93373.</span> [<a href="/pubmed/7677348" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=Characterization+of+the+imidazoline+binding+site+involved+in+regulation+of+insulin+secretion&amp;author=NG+Morgan&amp;author=SLF+Chan&amp;author=CA+Brown&amp;author=E+Tsoli&amp;volume=763&amp;publication_year=1995&amp;pages=361-373&amp;pmid=7677348&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Raddatz R, Parini A, Lanier SM. Imidazoline/guanidinium binding domains on monoamine oxidases: relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. <span><span class="ref-journal"><em>Journal of Biological Chemistry</em>. </span>1995;<span class="ref-vol">270</span>(46):27961\xe2\x80\x9327968.</span> [<a href="/pubmed/7499273" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Biological+Chemistry&amp;title=Imidazoline/guanidinium+binding+domains+on+monoamine+oxidases:+relationship+to+subtypes+of+imidazoline-binding+proteins+and+tissue-specific+interaction+of+imidazoline+ligands+with+monoamine+oxidase+B&amp;author=R+Raddatz&amp;author=A+Parini&amp;author=SM+Lanier&amp;volume=270&amp;issue=46&amp;publication_year=1995&amp;pages=27961-27968&amp;pmid=7499273&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Piletz JE, Andorn AC, Unnerstall JR, Halaris A. Binding of [3H]-p-aminoclonidine to <em>&#x003b1;</em>2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. <span><span class="ref-journal"><em>Biochemical Pharmacology</em>. </span>1991;<span class="ref-vol">42</span>(3):569\xe2\x80\x93584.</span> [<a href="/pubmed/1677571" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+Pharmacology&amp;title=Binding+of+[3H]-p-aminoclonidine+to+&#x003b1;2-adrenoceptor+states+plus+a+non-adrenergic+site+on+human+platelet+plasma+membranes&amp;author=JE+Piletz&amp;author=AC+Andorn&amp;author=JR+Unnerstall&amp;author=A+Halaris&amp;volume=42&amp;issue=3&amp;publication_year=1991&amp;pages=569-584&amp;pmid=1677571&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">Ernsberger P, Shen I-H. Membrane localization and guanine nucleotide sensitivity of medullary I1-imidazoline binding sites. <span><span class="ref-journal"><em>Neurochemistry International</em>. </span>1997;<span class="ref-vol">30</span>(1):17\xe2\x80\x9323.</span> [<a href="/pubmed/9116582" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurochemistry+International&amp;title=Membrane+localization+and+guanine+nucleotide+sensitivity+of+medullary+I1-imidazoline+binding+sites&amp;author=P+Ernsberger&amp;author=I-H+Shen&amp;volume=30&amp;issue=1&amp;publication_year=1997&amp;pages=17-23&amp;pmid=9116582&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Heemskerk FMJ, Dontenwill M, Greney H, Vonthron C, Bousquet P. Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem. <span><span class="ref-journal"><em>Journal of Neurochemistry</em>. </span>1998;<span class="ref-vol">71</span>(5):2193\xe2\x80\x932202.</span> [<a href="/pubmed/9798947" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Neurochemistry&amp;title=Evidence+for+the+existence+of+imidazoline-specific+binding+sites+in+synaptosomal+plasma+membranes+of+the+bovine+brainstem&amp;author=FMJ+Heemskerk&amp;author=M+Dontenwill&amp;author=H+Greney&amp;author=C+Vonthron&amp;author=P+Bousquet&amp;volume=71&amp;issue=5&amp;publication_year=1998&amp;pages=2193-2202&amp;pmid=9798947&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Piletz JE, Ivanov TR, Sharp JD, et al.  Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. <span><span class="ref-journal"><em>DNA and Cell Biology</em>. </span>2000;<span class="ref-vol">19</span>(6):319\xe2\x80\x93329.</span> [<a href="/pubmed/10882231" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=DNA+and+Cell+Biology&amp;title=Imidazoline+receptor+antisera-selected+(IRAS)+cDNA:+cloning+and+characterization&amp;author=JE+Piletz&amp;author=TR+Ivanov&amp;author=JD+Sharp&amp;volume=19&amp;issue=6&amp;publication_year=2000&amp;pages=319-329&amp;pmid=10882231&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Dontenwill M, Pascal G, Piletz JE, et al.  IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells. <span><span class="ref-journal"><em>Cell Death and Differentiation</em>. </span>2003;<span class="ref-vol">10</span>(8):933\xe2\x80\x93935.</span> [<a href="/pubmed/12868002" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+and+Differentiation&amp;title=IRAS,+the+human+homologue+of+Nischarin,+prolongs+survival+of+transfected+PC12+cells&amp;author=M+Dontenwill&amp;author=G+Pascal&amp;author=JE+Piletz&amp;volume=10&amp;issue=8&amp;publication_year=2003&amp;pages=933-935&amp;pmid=12868002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Dontenwill M, Piletz JE, Chen M, et al.  IRAS is an anti-apoptotic protein. <span><span class="ref-journal"><em>Annals of the New York Academy of Sciences</em>. </span>2003;<span class="ref-vol">1009</span>:400\xe2\x80\x93412.</span> [<a href="/pubmed/15028619" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=IRAS+is+an+anti-apoptotic+protein&amp;author=M+Dontenwill&amp;author=JE+Piletz&amp;author=M+Chen&amp;volume=1009&amp;publication_year=2003&amp;pages=400-412&amp;pmid=15028619&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Dupuy L, Urosevic D, Greney H, et al.  I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells. <span><span class="ref-journal"><em>Cell Death and Differentiation</em>. </span>2004;<span class="ref-vol">11</span>(9):1049\xe2\x80\x931052.</span> [<a href="/pubmed/15143350" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+and+Differentiation&amp;title=I1+imidazoline+receptor-mediated+effects+on+apoptotic+processes+in+PC12+cells&amp;author=L+Dupuy&amp;author=D+Urosevic&amp;author=H+Greney&amp;volume=11&amp;issue=9&amp;publication_year=2004&amp;pages=1049-1052&amp;pmid=15143350&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Piletz JE, Wang G, Zhu H. Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue. <span><span class="ref-journal"><em>Annals of the New York Academy of Sciences</em>. </span>2003;<span class="ref-vol">1009</span>:392\xe2\x80\x93399.</span> [<a href="/pubmed/15028618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=Cell+signaling+by+imidazoline-1+receptor+candidate,+IRAS,+and+the+nischarin+homologue&amp;author=JE+Piletz&amp;author=G+Wang&amp;author=H+Zhu&amp;volume=1009&amp;publication_year=2003&amp;pages=392-399&amp;pmid=15028618&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Alahari SK, Lee JW, Juliano RL. Nischarin, a novel protein that interacts with the integrin <em>&#x003b1;</em>5 subunit and inhibits cell migration. <span><span class="ref-journal"><em>Journal of Cell Biology</em>. </span>2000;<span class="ref-vol">151</span>(6):1141\xe2\x80\x931154.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2190593/">PMC free article</a>]</span> [<a href="/pubmed/11121431" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Cell+Biology&amp;title=Nischarin,+a+novel+protein+that+interacts+with+the+integrin+&#x003b1;5+subunit+and+inhibits+cell+migration&amp;author=SK+Alahari&amp;author=JW+Lee&amp;author=RL+Juliano&amp;volume=151&amp;issue=6&amp;publication_year=2000&amp;pages=1141-1154&amp;pmid=11121431&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Sun Z, Chang CH, Ernsberger P. Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells. <span><span class="ref-journal"><em>Journal of Neurochemistry</em>. </span>2007;<span class="ref-vol">101</span>:99\xe2\x80\x93108.</span> [<a href="/pubmed/17254010" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Neurochemistry&amp;title=Identification+of+IRAS/Nischarin+as+an+I1-imidazoline+receptor+in+PC12+rat+pheochromocytoma+cells&amp;author=Z+Sun&amp;author=CH+Chang&amp;author=P+Ernsberger&amp;volume=101&amp;publication_year=2007&amp;pages=99-108&amp;pmid=17254010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Molderings GJ, B&#x00151;nisch H, Br&#x00171;ss M, Wolf C, von K&#x00171;gelgen I, G&#x00151;thert M. S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I1 receptor ligands. <span><span class="ref-journal"><em>Neurochemistry International</em>. </span>2007;<span class="ref-vol">51</span>(8):476\xe2\x80\x93485.</span> [<a href="/pubmed/17559976" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurochemistry+International&amp;title=S1P-receptors+in+PC12+and+transfected+HEK293+cells:+molecular+targets+of+hypotensive+imidazoline+I1+receptor+ligands&amp;author=GJ+Molderings&amp;author=H+B&#x00151;nisch&amp;author=M+Br&#x00171;ss&amp;author=C+Wolf&amp;author=I+von+K&#x00171;gelgen&amp;volume=51&amp;issue=8&amp;publication_year=2007&amp;pages=476-485&amp;pmid=17559976&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Wu N, Su R-B, Xu B, et al.  IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence. <span><span class="ref-journal"><em>Biochemical Pharmacology</em>. </span>2005;<span class="ref-vol">70</span>(7):1079\xe2\x80\x931087.</span> [<a href="/pubmed/16112088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+Pharmacology&amp;title=IRAS,+a+candidate+for+I1-imidazoline+receptor,+mediates+inhibitory+effect+of+agmatine+on+cellular+morphine+dependence&amp;author=N+Wu&amp;author=R-B+Su&amp;author=B+Xu&amp;volume=70&amp;issue=7&amp;publication_year=2005&amp;pages=1079-1087&amp;pmid=16112088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Zhu H, Hayes J, Chen M, Baldwin J, Piletz JE. Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS. <span><span class="ref-journal"><em>Annals of the New York Academy of Sciences</em>. </span>2003;<span class="ref-vol">1009</span>:439\xe2\x80\x93446.</span> [<a href="/pubmed/15028623" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of+Sciences&amp;title=Relationship+between+platelet+imidazoline+receptor-binding+peptides+and+candidate+imidazoline-1+receptor,+IRAS&amp;author=H+Zhu&amp;author=J+Hayes&amp;author=M+Chen&amp;author=J+Baldwin&amp;author=JE+Piletz&amp;volume=1009&amp;publication_year=2003&amp;pages=439-446&amp;pmid=15028623&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Ponting CP. Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3- kinases: binding partners of \nSH3 domains? <span><span class="ref-journal"><em>Protein Science</em>. </span>1996;<span class="ref-vol">5</span>(11):2353\xe2\x80\x932357.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2143296/">PMC free article</a>]</span> [<a href="/pubmed/8931154" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Protein+Science&amp;title=Novel+domains+in+NADPH+oxidase+subunits,+sorting+nexins,+and+PtdIns+3-+kinases:+binding+partners+of+&#10;SH3+domains?&amp;author=CP+Ponting&amp;volume=5&amp;issue=11&amp;publication_year=1996&amp;pages=2353-2357&amp;pmid=8931154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Nelson PN, Reynolds GM, Waldron EE, Ward E, Giannopoulos K, Murray PG. Monoclonal antibodies. <span><span class="ref-journal"><em>Molecular Pathology</em>. </span>2000;<span class="ref-vol">53</span>(3):111\xe2\x80\x93117.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1186915/">PMC free article</a>]</span> [<a href="/pubmed/10897328" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Pathology&amp;title=Monoclonal+antibodies&amp;author=PN+Nelson&amp;author=GM+Reynolds&amp;author=EE+Waldron&amp;author=E+Ward&amp;author=K+Giannopoulos&amp;volume=53&amp;issue=3&amp;publication_year=2000&amp;pages=111-117&amp;pmid=10897328&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Yuan X, Cong Y, Hao J, et al.  Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. <span><span class="ref-journal"><em>Journal of Molecular Biology</em>. </span>2004;<span class="ref-vol">339</span>(1):131\xe2\x80\x93144.</span> [<a href="/pubmed/15123426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Molecular+Biology&amp;title=Regulation+of+LIP+level+and+ROS+formation+through+interaction+of+H-ferritin+with+G-CSF+receptor&amp;author=X+Yuan&amp;author=Y+Cong&amp;author=J+Hao&amp;volume=339&amp;issue=1&amp;publication_year=2004&amp;pages=131-144&amp;pmid=15123426&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Yuan X, Li J, Shan Y, et al.  Subcellular localization and membrane association of SARS-CoV 3a protein. <span><span class="ref-journal"><em>Virus Research</em>. </span>2005;<span class="ref-vol">109</span>(2):191\xe2\x80\x93202.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7114198/">PMC free article</a>]</span> [<a href="/pubmed/15763150" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virus+Research&amp;title=Subcellular+localization+and+membrane+association+of+SARS-CoV+3a+protein&amp;author=X+Yuan&amp;author=J+Li&amp;author=Y+Shan&amp;volume=109&amp;issue=2&amp;publication_year=2005&amp;pages=191-202&amp;pmid=15763150&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Deng L-W, Chiu I, Strominger JL. MLL5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. <span><span class="ref-journal"><em>Proceedings of the National Academy of Sciences of the United States of America</em>. </span>2004;<span class="ref-vol">101</span>(3):757\xe2\x80\x93762.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC321754/">PMC free article</a>]</span> [<a href="/pubmed/14718661" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;title=MLL5+protein+forms+intranuclear+foci,+and+overexpression+inhibits+cell+cycle+progression&amp;author=L-W+Deng&amp;author=I+Chiu&amp;author=JL+Strominger&amp;volume=101&amp;issue=3&amp;publication_year=2004&amp;pages=757-762&amp;pmid=14718661&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Harrison RG. Expression of soluble heterologous proteins via fusion with NusA protein. <span><span class="ref-journal"><em>Innovations</em>. </span>2000;<span class="ref-vol">11</span>:4\xe2\x80\x937.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Innovations&amp;title=Expression+of+soluble+heterologous+proteins+via+fusion+with+NusA+protein&amp;author=RG+Harrison&amp;volume=11&amp;publication_year=2000&amp;pages=4-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Lim K-P, Hong W. Human nischarin/imidazoline receptor antisera-selected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region. <span><span class="ref-journal"><em>Journal of Biological Chemistry</em>. </span>2004;<span class="ref-vol">279</span>(52):54770\xe2\x80\x9354782.</span> [<a href="/pubmed/15475348" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Biological+Chemistry&amp;title=Human+nischarin/imidazoline+receptor+antisera-selected+protein+is+targeted+to+the+endosomes+by+a+combined+action+of+a+PX+domain+and+a+coiled-coil+region&amp;author=K-P+Lim&amp;author=W+Hong&amp;volume=279&amp;issue=52&amp;publication_year=2004&amp;pages=54770-54782&amp;pmid=15475348&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Zheng B, Ma YC, Ostrom RS, et al.  RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. <span><span class="ref-journal"><em>Science</em>. </span>2001;<span class="ref-vol">294</span>:1845\xe2\x80\x931847.</span> [<a href="/pubmed/11729322" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=RGS-PX1,+a+GAP+for+GalphaS+and+sorting+nexin+in+vesicular+trafficking&amp;author=B+Zheng&amp;author=YC+Ma&amp;author=RS+Ostrom&amp;volume=294&amp;publication_year=2001&amp;pages=1845-1847&amp;pmid=11729293&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2723995&amp;issue-id=173107&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Journal of Biomedicine and Biotechnology</span> are provided here courtesy of <strong>Hindawi Limited</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2723995/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2723995/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2723995/pdf/JBB2009-973754.pdf">PDF (2.0M)</a></li> | <li><a href="#" data-citationid="PMC2723995" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2723995%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2723995%2F&amp;text=Generation%20and%20Characterization%20of%20Novel%20Human%20IRAS%20Monoclonal%20Antibodies"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2723995%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19672324" data-aiid="2723995" data-aid="2723995" data-iid="173107" data-domainid="94" data-domain="jbb" data-accid="PMC2723995" data-md5="7e60fc8d1fd480de5ec8aa87bd8f78cd"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:20:44-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A87D7E9A471110000000000980098&amp;ncbi_session=8A1A87D7E9A47DC1_0152SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2723995%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jbb&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2723995/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A87D7E9A47DC1_0152SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'